Categories: Latest

Experts from Bangalore stress on the need for newborn screening to detect Congenital Hypothyroidism

Bangalore, December 14, 2016: Our country is slowly emerging as a world leader in medical advancements. India is now a major provider of health services and we have some of the most highly skilled and qualified medical providers in the world. However, quality healthcare and lack of national care has produced severe health issues throughout the nation. One such major health concern is that of ‘Congenital Hypothyroidism’ (CH) which affects 1 in 2640 newborns in India.

To get discussions rolling, Dr Mala Dharmalingam (Professor and Head of Department, MS Ramaiah Medical College), Dr Anjana Hulse, (Consultant Pediatric Endocrinologist, Apollo Hospitals), Dr Praveen Ramachandra, (Director – Endocrinologist, Diaplus Clinic, Yelahanka Newtown) and Dr Nishita Rao, (Specialist in Obstetrics & Gynaecology, Lakshmi Maternity & Surgical Centre) came together to evaluate associated risks and minimize possible threats for Congenital Hypothyroidism by early intervention.

Highlighting the current situation in Bangalore, Dr Mala Dharmalingam, (Professor and Head of Department, MS Ramaiah Medical College) said, “Thyroid hormone plays an important role in development of the brain and other functions of the body like metabolism, growth and development and deficiency of this causes Congenital Hypothyroidism. All newborns should definitely be screened for CH at birth. If not screened, diagnosed and treated in appropriate time; it can lead to mental retardation. Once a baby is diagnosed with CH, the baby is started on thyroid hormone replacement. Today, though the levels of awareness remain low in general, we have seen a considerable increase in number of babies being screened since most gynecologists are now recommending screening at birth.”

Most newborns with Congenital Hypothyroidism appear normal at birth, even if there is complete lack of development of the thyroid gland. This is because a small amount of thyroid hormone (T4) from the mother is transferred to the baby during pregnancy. Around 10 per cent of infants with Congenital Hypothyroidism have other associated abnormalities; most commonly witnessed are cardiac abnormalities followed by abnormalities of the nervous system and eyes.

Stressing on the importance of timely identification and treatment, Dr Anjana Hulse(Consultant Pediatric Endocrinologist, Apollo Hospitals), stated, “In most cases of Congenital Hypothyroidism, children do not have evident symptoms and they appear to be physically normal and therefore difficult to detect. There is a need to have a legislation which mandates universal screening programmes. The treatment is simple and cost effective. Levothyroxine given orally everyday is the treatment of choice. No baby should be left to suffer the circumstances because he/she was undiagnosed.”

Highlighting the precautionary measures expecting mothers should take, Dr Nishita Rao, (Specialist in Obstetrics & Gynaecology, Lakshmi Maternity & Surgical Centre), said, “The birth of their baby is probably one of the most memorable moments in a parent’s life. In order to keep the newborn safe from any complications, screening is extremely important.What is most important is for expecting mothers to be more aware and keep thyroid levels under a constant check. Early detection and supplementation of thyroid hormone is easy, inexpensive and effective. Small and simple preventive measures can reduce large number of complications.”

On a concluding note, Dr Praveen Ramachandra, (Director – Endocrinologist, Diaplus Clinic, Yelahanka Newtown),“Of all endocrine disorders that a child can be born with, CH, is not only one of the most common, but also the most detrimental if not detected in time. If every new born is screened; no child will suffer from disastrous effects of Congenital Hypothyroidism.”

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

The future of healthcare: Five key trends for providers in 2025

By Srinath Rao, Senior Vice President, CitiusTech A few decades back, the purpose of watches…

21 hours ago

Switzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack Report

Pharmapack Europe: 'Basel the best location for drug device innovation in Europe thanks to combination…

21 hours ago

Quote on HMPV by Doctors of Super Specialty Hospitals

New Delhi, January 07, 2025: HMP virus can travel to the brain, or it can…

2 days ago

Advisory For Hmpv – Key Preventative Measures

~ Co-authored by Dr Sanjith Saseedharan, Director-Critical Care, S. L. Raheja Hospital- A Fortis Associate…

2 days ago

40% of Doctor Appointments Dedicated to Family and Friends, Reveals MediBuddy’s 2024 Data

Patients Embrace Flexibility with 37% of Online Doctor Consultations now happening even After 6 PM,…

3 days ago

American Institute of Pathology & Laboratory Sciences (Ampath) in Collaboration Expands its Diagnostic Services in Uttar Pradesh

Launches Advanced Pathology Laboratory Offering Over 2500+ Tests in collaboration with Parashar Pathology Clinic in…

3 days ago